Aimovig 70 Mg / 1 Ml Sc 1 Prefilled Pen

The FDA announced approval on May 17 of a novel preventive treatment for migraine headaches. Aimovig is the first in a new class of migraine-specific drugs that works by blocking an action of a protein that is increased in people with migraine during headache attacks. A migraine is a chronic disorder of the brain with recurrent severe attacks, from one or two times a year to nearly daily. The main feature of these attacks is severe headache. Other common features are nausea or even vomiting. Many people have sensitivity to light, odors or sounds and are unable to carry on daily activity. he needle is hidden inside the safety guard Must be stored in the refrigerator (at 36-46°F/2-8°C) in the original carton to protect it from light Please don’t freeze or shake it Once out of the refrigerator, it should be kept at room temperature (up to 25°C/77°F) in the original carton, and it must be used within 7 days Throw it away if it’s been at room temperature for more than 7 days Leave the autoinjector at room temperature for at least 30 minutes before injecting